Biotin and Thyroid Testing: Critical Interference Warning
Patients must discontinue biotin supplements at least 8 hours before thyroid testing for 5 mg/day doses, and 1-2 days for 10 mg/day doses, as biotin causes clinically significant false results in most immunoassay platforms 1, 2.
Mechanism of Interference
Biotin interferes with immunoassays that use biotin-streptavidin binding technology, which includes most modern thyroid function tests. The FDA explicitly warns that biotin levels above recommended daily allowances cause interference with hormone tests and may lead to incorrect results 1.
The interference pattern is predictable but dangerous:
- Sandwich assays (TSH): Falsely LOW results
- Competitive assays (FT4, FT3): Falsely HIGH results
This creates a spurious pattern mimicking hyperthyroidism (low TSH, high FT4/FT3), leading to misdiagnosis in over 50% of documented cases 3.
Platform-Specific Vulnerability
Critical platform differences exist:
- Roche cobas e602: Significant interference occurs; newer reagents tolerate 1000-3000 ng/mL biotin depending on specific test 4
- Beckman UniCel DxI 800: Significant interference documented 2
- Abbott Architect 2000: No interference observed even at high biotin levels 2
The biotin concentration threshold for 20% assay change is as low as 500 ng/mL on older platforms 4.
Clinical Washout Periods
Research demonstrates clear washout timelines 2:
- 5 mg/day biotin: 8-hour washout sufficient
- 10 mg/day biotin: 1-2 day washout required (platform-dependent)
The serum biotin level, not the dose, is the primary determinant of interference 5. A serum biotin level of 80.35 µg/L predicts interference with 96.2% sensitivity and 94.4% specificity 5.
High-Risk Populations
Be especially vigilant in:
- Hemodialysis patients: Mean biotin levels 3.282 ng/mL 4
- ICU patients: Mean biotin levels 3.212 ng/mL 4
- Children with biotinidase deficiency: 60% show interference on standard assays 5
These patients often receive biotin-containing supplements or multivitamins without documentation.
Detection Algorithm
When thyroid function tests show discordant results:
- Ask specifically about biotin supplementation - patients often don't report over-the-counter supplements
- Check for pattern: Low TSH + High FT4/FT3 suggests biotin interference
- Verify platform susceptibility with your laboratory
- Retest after appropriate washout period (8 hours to 2 days based on dose)
- Consider alternative platform (Abbott system if available) 2
- Laboratory can use streptavidin magnetic particles to neutralize biotin in samples 5
Common Pitfalls
- Assuming all platforms are equally affected: Abbott systems show no interference while Roche and Beckman systems do 2
- Not asking about supplements: Biotin is ubiquitous in hair/nail/skin supplements, often at 5-10 mg doses
- Testing too soon after discontinuation: 8 hours minimum for standard doses 2
- Ignoring the 1% prevalence: With widespread thyroid testing, this affects substantial patient numbers 3
Laboratory Considerations
The AACC guidance document emphasizes that laboratories and clinicians must work together to prevent biotin interference 6. Your laboratory should know their platform's biotin tolerance and have protocols for suspected interference cases.
Do not rely on TSH alone when biotin interference is possible - FT3 and FT4 levels remain more stable across prandial states and can help confirm true thyroid status 7.